THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

James George to Adrenal Cortex Hormones

This is a "connection" page, showing publications James George has written about Adrenal Cortex Hormones.
Connection Strength

1.563
  1. Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura. Am J Hematol. 2012 May; 87 Suppl 1:S88-91.
    View in: PubMed
    Score: 0.388
  2. Preventable deaths during initial episodes of acquired Thrombotic Thrombocytopenic Purpura: Past and future. Am J Hematol. 2019 09; 94(9):E242-E244.
    View in: PubMed
    Score: 0.162
  3. Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2016 06 16; 127(24):3092-4.
    View in: PubMed
    Score: 0.129
  4. The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura. Blood. 2015 Mar 05; 125(10):1526-31.
    View in: PubMed
    Score: 0.118
  5. Bone marrow necrosis discovered in a patient with suspected thrombotic thrombocytopenic purpura. Am J Hematol. 2015 Mar; 90(3):264-6.
    View in: PubMed
    Score: 0.116
  6. Sequence of treatments for adults with primary immune thrombocytopenia. Am J Hematol. 2012 May; 87 Suppl 1:S12-5.
    View in: PubMed
    Score: 0.097
  7. Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes. Hematology Am Soc Hematol Educ Program. 2012; 2012:604-9.
    View in: PubMed
    Score: 0.096
  8. How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood. 2010 Nov 18; 116(20):4060-9.
    View in: PubMed
    Score: 0.087
  9. Addendum to corticosteroid side effects and risk for bleeding in immune thrombocytopenic purpura: patient perspectives. Eur J Haematol. 2009 Nov; 83(5):497-8.
    View in: PubMed
    Score: 0.081
  10. Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol. 2009 Sep; 83(3):175-82.
    View in: PubMed
    Score: 0.079
  11. Thrombotic thrombocytopenic purpura: 2008 update. Cleve Clin J Med. 2008 May; 75(5):369-75.
    View in: PubMed
    Score: 0.074
  12. An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura. Br J Haematol. 2007 Jan; 136(1):146-9.
    View in: PubMed
    Score: 0.067
  13. Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists. Am J Med Sci. 2014 Mar; 347(3):190-4.
    View in: PubMed
    Score: 0.028
  14. Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion. 2012 Dec; 52(12):2525-32; quiz 2524.
    View in: PubMed
    Score: 0.024
  15. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med. 2006 Oct 19; 355(16):1672-81.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES